2m 2m 2m 2m 2m 2m 2m
IMMUNEERING-A (IMRX)
NASDAQ
$4.52-$0.02 (-0.35%)
Price as of Jun 23, 2026 7:46 PM EDT- $287.3MMarket Cap
- 54.42%1-Year Change
- BiotechnologyIndustry
IMMUNEERING-A (IMRX)
$4.52-$0.02 (-0.35%)
IMRX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $4.54 | ||
Change | +$0.10 (+2.25%) | ||
Open | $4.38 | ||
High | $4.67 | ||
Low | $4.38 | ||
Previous Close | $4.44 | ||
Volume | 936,200 | ||
30-Day Average Volume | 2,047,902 | ||
1-Week Change | 10.73% | ||
1-Month Change | -15.77% | ||
1-Year Change | 54.42% | ||
3-Year Change | -55.84% | ||
5-Year Change | 8,564.12% | ||
Fundamentals | |||
Shares Outstanding | 64.7M | ||
Total Assets | $214.8M | ||
Market Cap | $287.3M | ||
Enterprise Value | $239.9M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$13.5M | ||
Free Cash Flow | -$18.5M | ||
EBIT | -$13.5M | ||
EBITDA | -$13.5M | ||
Net Working Capital | $156.4M | ||
EPS | -$0.21 | ||
Enterprise Value/EBITDA | -18 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 1 | ||
P/E | -21 | ||
PEG | 1 | ||
Price/Free Cash Flow | -16 | ||
Price/Operating Cash Flow | -16 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue